American Association for Cancer Research (AACR) shared a post on LinkedIn:
“Before immunotherapy pioneer Carl June delivered the opening keynote address at AACR Kidney 26, he discussed the path of CAR T-cell therapy from research in the 80s to HIV research in the 90s and, more recently, cancer research, with blood cancers and now with solid tumors.”
Other posts featuring Carl June on OncoDaily.